missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human GALNT14 (aa 143-260) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65057 (PA5-65057. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
GALNT14 (EC 2.4.1.41) belongs to a large subfamily of glycosyltransferases residing in the Golgi apparatus. GALNT enzymes catalyze the first step in the O-glycosylation of mammalian proteins by transferring N-acetyl-D-galactosamine (GalNAc) to peptide substrates.
Specifications
Specifications
| Accession Number | Q96FL9 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 79623 |
| Name | Human GALNT14 (aa 143-260) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 0610033M06Rik; FLJ12691; FLJ13977; GalNac-T10; GalNac-T14; GALNT14; GALNT15; Polypeptide GalNAc transferase 14; polypeptide N-acetylgalactosaminyltransferase 14; polypeptide N-acetylgalactosaminyltransferase 15; pp-GaNTase 14; protein-UDP acetylgalactosaminyltransferase 14; si:ch211-147c1.1; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase T10; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14); UNQ2434/PRO4994 |
| Common Name | GALNT14 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction